Yttrium-90 and Rhenium-188 radiopharmaceuticals for radionuclide therapy
A key requirement for the effective implementation of the therapeutic approach, based on the intravenous administration of radiolabelled compounds (radionuclide therapy), is the sufficient availability of radionuclides with appropriate physical characteristics. Based on their nuclear properties, 188...
Guardado en:
| Otros Autores: | |
|---|---|
| Formato: | Sin ejemplares |
| Lenguaje: | Inglés |
| Publicado: |
Vienna :
IAEA,
2015.
|
| Colección: | IAEA Radioisotopes and Radiopharmaceuticals Series,
no. 5 |
| Materias: | |
| Acceso en línea: | Texto completo Tapa |
